Online citations, reference lists, and bibliographies.
← Back to Search

Invited Review: Development Of Fat Emulsions

A. Wretlind
Published 1981 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
: The studies on the possibility of preparing IV fat emulsions began in the 1920's; since then, a very large number of emulsions with various fats and emulsifiers have been investigated. However, none of the early fat emulsions could be used safely in man. By the trial and error technique, a method was finally found to prepare soybean oil and egg yolk phospholipids to make a fat emulsion that had a low incidence of adverse reactions. A newly devised biological test system based on nutritional concepts was of crucial importance. It meant that any energy supplying nutrient should be tested in animals in relation to the energy requirement of the species used and not identical to the human dose/kg body weight as in the "classical" toxicity and tolerance tests. With the development of well-tolerated IV fat emulsions it has been possible to devise a TPN regimen that is adequate from a nutritional point of view as well as an adequate alternative to the ordinary oral food. This regimen, which can be administered by the peripheral route, means that the original aims for developing IV fat emulsions were finally achieved.
This paper references
Parenteral nutrition; the vasodepressor activity of soybean phosphatide preparations.
R. Geyer (1949)
10.1016/S0022-3476(35)80176-5
The intravenous administration of fat
L. Holt (1935)
10.1111/J.1748-1716.1965.TB04244.X
Definition of two Distinct Processes in Activation during Potassium-Induced Contractures of Frog's Skeletal Muscle
G. B. Frank (1965)
10.1097/00000658-197508000-00015
Nitrogen Balance in Patients Receiving Either Fat or Carbohydrate For Total Intravenous Nutritiion
A. Gazzaniga (1975)
10.1172/JCI108252
Metabolic studies in total parenteral nutrition with lipid in man. Comparison with glucose.
K. N. Jeejee hoy (1976)
10.1016/0002-9343(49)90594-X
Study of complete parenteral alimentation on dogs.
H. Meng (1949)
10.1093/AJCN/29.3.255
The role of Intralipid in prolonged parenteral nutrition. I. As a caloric substitute for glucose.
J. W. Broviac (1976)
10.1016/0026-0495(79)90188-4
Availability of apolipoprotein CII in relation to the maximal removal capacity for an infused triglyceride emulsion in man.
D. Erkelens (1979)
10.1097/00003246-198001000-00003
Nutritional requirements of adult surgical patients.
D. Elwyn (1980)
10.1177/014860718000400221
Effect of insulin on metabolic response to injury.
S. Allison (1980)
10.1111/J.1748-1716.1957.TB01502.X
The toxicity of low-molecular triglycerides.
A. Wretlind (1957)
10.1172/JCI107171
Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man.
R. Havel (1973)
10.3181/00379727-37-9660
Urinary Output of Nitrogen as Influenced by Intravenous Injection of a Mixture of Amino-Acids
R. Elman (1938)
Composition, preparation and testing of an intravenous fat emulsion.
Meyer Ce (1957)
10.1111/J.1600-0773.1961.TB00323.X
Pharmacological effects of fatty acids, triolein and cottonseed oil.
L. Oro (1961)
10.1016/0016-5085(81)90198-0
Glucose or fat as a nonprotein energy source? A controlled clinical trial in gastroenterological patients requiring intravenous nutrition.
J. Macfie (1981)
10.1111/J.1753-4887.1981.TB06788.X
Long-term total parenteral nutrition with growth, development, and positive nitrogen balance.
S. Dudrick (1968)
10.1620/TJEM.18.120
Verhalten der Ölemulsionen verschiedener Dispersität nach intravenöser Darreichung mit besonderer Berück=sichtigung der Fettembolie der Lunge
G. Sato (1931)



This paper is referenced by
10.1007/978-3-642-77369-3_4
Liver-Specific Particulate Contrast Agents: An Overview
K. Ivancev (1993)
10.3390/ma11020321
Emerging Nanomedicine Therapies to Counter the Rise of Methicillin-Resistant Staphylococcus aureus
Alan J Hibbitts (2018)
10.1016/S0168-3659(97)00046-1
Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential
K. Westesen (1997)
10.1177/088453360101600508
Classic Article: Commentary on “Metabolic Studies in Total Parenteral Nutrition with Lipid in Man. Comparison with Glucose
S. J. Miller (2001)
10.1016/j.ejpb.2017.05.008
Novel strategies for the formulation and processing of poorly water‐soluble drugs
K. Göke (2018)
10.1177/0148607192016002136
Composition of phospholipid fatty acids in red blood cell membranes of patients in intensive care units: effects of different intakes of soybean oil, medium-chain triglycerides, and black-currant seed oil.
M. Diboune (1992)
10.1177/0148607195019002125
Effects of free glycerol contained in intravenous fat emulsion on plasma triglyceride determination.
T. Howdieshell (1995)
10.1016/j.suc.2011.02.003
The prevention and treatment of intestinal failure-associated liver disease in neonates and children.
D. Nehra (2011)
10.1016/S0261-5614(98)80319-1
MCT/LCT emulsion ameliorate liver fat deposition in insulin-treated diabetic rats receiving total parenteral nutrition.
S. Yeh (1998)
10.1016/S0378-5173(97)04890-4
Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles
K. Westesen (1997)
10.1016/j.jcis.2011.04.080
Preparation and characterization of highly stable lipid nanoparticles with amorphous core of tuneable viscosity.
Thomas Delmas (2011)
10.1016/0261-5614(93)90028-3
Intravascular metabolism of different fatty acids during lipid infusion in man.
V. Siderova (1993)
10.1248/BPB.31.673
Formulation, preparation and evaluation of an intravenous emulsion containing Brucea javanica oil and Coix Seed oil for anti-tumor application.
Ye-ling Yu (2008)
10.1038/s41430-020-0584-9
A serendipitous voyage in the field of nutrition and metabolism in health and disease: a translational adventure
P. Soeters (2020)
10.1177/088453360101600404
Intravenous Lipid Emulsions: 2001
D. Driscoll (2001)
10.1211/0022357055894
Tumour targeting: biological factors and formulation advances in injectable lipid nanoparticles
V. Shenoy (2005)
10.1016/S0261-5614(98)80047-2
Physicochemical stability of all-in-one mixtures inclinical setting
D. Driscoll (1998)
10.3305/NUTR
Estudio aleatorio de dos emulsiones grasas diferentes en la nutrición parenteral total del enfermo quirúrgico desnutrido: efecto sobre la morbilidad infecciosa y la mortalidad
T. Grau (2003)
10.1002/ANGE.19911030522
Hochstabile Liposomen aus perfluoralkylierten Glycerophosphocholinen
C. Santaella (1991)
10.1016/0378-5173(91)90289-Z
An interfacial equilibria model for the electrokinetic properties of a fat emulsion
S. B. Hall (1991)
10.1002/ncp.10496
ASPEN Lipid Injectable Emulsion Safety Recommendations, Part 1: Background and Adult Considerations.
J. Mirtallo (2020)
10.3109/15563650.2016.1151528
Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration
B. Hayes (2016)
10.1016/j.clnu.2008.08.011
Fine vs. coarse complete all-in-one admixture infusions over 96 hours in rats: fat globule size and hepatic function.
D. Driscoll (2008)
Lipid metabolism: comparison of stress and nonstressed states.
D. Waitzberg (2005)
10.1177/0115426592007004187
Intravenous fat emulsions in clinical practice.
K. Warshawsky (1992)
10.1016/J.ADDR.2012.09.021
Solid lipid nanoparticles
W. Mehnert (2012)
10.1079/PNS19900043
New developments in fat emulsions.
Y. Carpentier (1990)
10.1007/BF03040501
Cholesterol improves the utilization of parenteral lipid emulsions
W. Druml (2009)
10.1016/J.ADDR.2003.12.002
Solid lipid nanoparticles for parenteral drug delivery.
S. Wissing (2004)
10.1097/MPG.0b013e3181bbf51e
Parenteral Fish Oil as Monotherapy Prevents Essential Fatty Acid Deficiency in Parenteral Nutrition–dependent Patients
V. E. de Meijer (2010)
10.1053/j.sempedsurg.2009.11.004
Innovative parenteral and enteral nutrition therapy for intestinal failure.
H. Le (2010)
10.2298/VSP130429028P
Intravenous fat emulsion in clinical practice: nutrient and antidote.
Vesna Putić (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar